Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Cash Inflow / Outflow ₹19 Cr₹155 Cr₹-93 Cr₹106 Cr₹-19 Cr

What is the latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA ?

The latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA is ₹19 Cr based on Mar2023 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2023₹19 Cr
Mar2022₹155 Cr
Mar2021₹-93 Cr
Mar2020₹106 Cr
Mar2019₹-19 Cr

How is Net Cash Inflow / Outflow of MANKIND PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2023 ₹19 Cr
-87.48
Mar2022 ₹155 Cr
Positive
Mar2021 ₹-93 Cr
Negative
Mar2020 ₹106 Cr
Positive
Mar2019 ₹-19 Cr -

Compare Net Cash Inflow / Outflow of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,809.5 Cr -6.5% -7.6% 57% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹368,598.0 Cr 2% -0.3% 59.8% Stock Analytics
CIPLA ₹114,654.0 Cr 6% 2.8% 50.4% Stock Analytics
DIVIS LABORATORIES ₹104,348.0 Cr 3.7% 5.8% 17.3% Stock Analytics
ZYDUS LIFESCIENCES ₹101,499.0 Cr 2.6% 7.9% 94.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,429.4 Cr -1.3% -2.8% 31.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.5%

-7.6%

57%

SENSEX

1.7%

-0.8%

19%


You may also like the below Video Courses